HiroPharmaConsulting (R) Granted Patent for AI-enabled Reliability Assurance Method for Pharmacovigilance Systems

HiroPharmaConsulting (R) Co., Ltd. announced that it has received a patent for an innovative Good Pharmacovigilance Practice (GVP) Computerized System Validation (CSV) methodology designed to ensure the reliability of pharmacovigilance systems equipped with AI functions. This patent represents Japan's first intellectual property specifically dedicated to the reliability assurance of AI-enabled pharmacovigilance systems. The Japan Patent […]

SEALSQ Makes Strategic Investment in EeroQ to Accelerate Its “Quantum Made in USA” Strategy

(NASDAQ:LAES), Geneva, Switzerland, Dec. 04, 2025 (GLOBE NEWSWIRE) — SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today announced a strategic investment in EeroQ, a U.S.-based quantum chip design company pioneering a breakthrough approach to building a quantum computer

Navatar and Inven Partner to Deliver AI-Powered Deal Origination for Private Equity and M&A Advisory On Salesforce

A Media Snippet accompanying this announcement is available by clicking on this link. LONDON and NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) — Navatar, the leading CRM platform for private markets, today announced a strategic partnership with Inven, the AI-powered platform for discovering and analyzing private companies. The partnership integrates Inven's advanced deal-sourcing intelligence directly

Addex Therapeutics Reports 2025 Third Quarter Financial Results and Provides Corporate Update

(SWX:ADXN), Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, December 4, 2025 – Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today reported its financial results for the three-month and nine-month periods ended September 30, 2025, and

Addex Therapeutics Reports 2025 Third Quarter Financial Results and Provides Corporate Update

Addex Therapeutics Reports 2025 Third Quarter Financial Results and Provides Corporate Update GlobeNewswire December 04, 2025 Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, December 4, 2025 – Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, today

SEALSQ Makes Strategic Investment in EeroQ to Accelerate Its “Quantum Made in USA” Strategy

SEALSQ Makes Strategic Investment in EeroQ to Accelerate Its “Quantum Made in USA” Strategy GlobeNewswire December 04, 2025 Geneva, Switzerland, Dec. 04, 2025 (GLOBE NEWSWIRE) — SEALSQ Corp (NASDAQ: LAES) (“SEALSQ” or “Company”), a company that focuses on developing and selling Semiconductors, PKI, and Post-Quantum technology hardware and software products, today announced a strategic investment

Navatar and Inven Partner to Deliver AI-Powered Deal Origination for Private Equity and M&A Advisory On Salesforce

Navatar and Inven Partner to Deliver AI-Powered Deal Origination for Private Equity and M&A Advisory On Salesforce GlobeNewswire December 04, 2025 A Media Snippet accompanying this announcement is available by clicking on this link. LONDON and NEW YORK, Dec. 04, 2025 (GLOBE NEWSWIRE) — Navatar, the leading CRM platform for private markets, today announced a

Savory Ingredients Market Size to Worth USD 18.99 Billion by 2034 | Towards FnB

Savory Ingredients Market Size to Worth USD 18.99 Billion by 2034 | Towards FnB According to Towards FnB, the global savory ingredients market size is evaluated at USD 12.45 billion in 2025 and is anticipated to hit USD 18.99 billion by 2034, reflecting at a CAGR of 4.8% from 2025 to 2034. This expansion is

Check Point Software Announces Pricing of Upsized Private Offering of $1.75 Billion of 0.00% Convertible Senior Notes due 2030

(NASDAQ:CHKP), TEL AVIV, Israel, Dec. 03, 2025 (GLOBE NEWSWIRE) — Check Point Software Technologies Ltd. (Nasdaq: CHKP), a pioneer and global leader of cyber security solutions, today announced the pricing of $1.75 billion aggregate principal amount of 0.00% Convertible Senior Notes due 2030 (the “Notes”) in a private offering (the “Offering”) to qualified institutional buyers

Check Point Software Announces Pricing of Upsized Private Offering of $1.75 Billion of 0.00% Convertible Senior Notes due 2030

Check Point Software Announces Pricing of Upsized Private Offering of $1.75 Billion of 0.00% Convertible Senior Notes due 2030 GlobeNewswire December 04, 2025 TEL AVIV, Israel, Dec. 03, 2025 (GLOBE NEWSWIRE) — Check Point Software Technologies Ltd. (Nasdaq: CHKP), a pioneer and global leader of cyber security solutions, today announced the pricing of $1.75 billion

Scroll to Top